MIAMI, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company, today announced that it has engaged Hayden IR, a nationally recognized investor relations and capital markets communications firm, to support the Company’s investor outreach, communications strategy, and market awareness initiatives. The engagement follows ETST’s successful completion of its FINRA 15c-211 clearance and advances its strategy of scaling its businesses into ...

Core Insights - Earth Science Tech, Inc. (ETST) reported significant financial growth in its second fiscal quarter, with a 71% year-over-year increase in total assets and a 22.65% increase since the last fiscal year-end [3][7]. Financial Performance - Total assets rose to $8.66 million, up from $5.04 million in Q2 2024, marking a 71.64% increase year-over-year [7]. - Year-to-date, total assets increased from $7.07 million at the end of March 2025 to $8.66 million [7]. - The company reduced its outstanding common shares by 3.57% to 292.8 million, reflecting a commitment to enhancing shareholder value [7]. - Quarterly net profit increased by 18.48%, reaching $0.94 million [7]. - Quarterly revenue grew by 6.24% to $9.05 million [7]. - Gross profit for the quarter rose by 7.3% to $6.72 million [7]. Business Operations - ETST operates as a strategic holding company focused on acquiring and optimizing high-potential businesses, including compounding pharmaceuticals, telemedicine, and real estate development [3]. - The company’s subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, and others, which contribute to its diversified operations [3][4][5][6][9]. - RxCompoundStore.com is a licensed compounding pharmacy serving multiple states and is pursuing further licensure [4]. - Mister Meds, acquired in October 2024, has advanced compounding capabilities and is expanding its licensure [5]. - Peaks Curative operates a telemedicine platform and has recently entered the veterinary market through an acquisition [6].

Core Viewpoint - Earth Science Tech, Inc. has approved a significant enhancement and a two-year extension of its common stock repurchase program, increasing total authorization to $10 million, which will now run through December 31, 2027 [1][2][3] Repurchase Program Details - The company has already deployed over $1.8 million to repurchase 20,834,214 shares since the program's inception on January 29, 2024, reflecting a commitment to enhancing shareholder value [2][4][8] - The remaining authorization for the repurchase program is $8,169,104.50, with the new expiration date set for December 31, 2027 [8] Company Overview - Earth Science Tech, Inc. operates as a strategic holding company focused on acquiring and scaling high-potential businesses, with current operations in compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries [5][6] - The company's subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, and others, each specializing in different aspects of healthcare and real estate [5][7][9]

Core Insights - Earth Science Tech, Inc. (ETST) reported significant financial and operational developments for the first fiscal quarter ending June 30, 2025, highlighting a strategic shift towards maximizing the value of its current divisions after a period of acquisitions [1][2]. Financial Highlights - Total assets increased by 61% to $7.69 million as of June 30, 2025, compared to $4.77 million in the prior-year period [5]. - Revenue generated was $8.7 million as of June 30, 2025, up from $8.5 million in the prior-year period [5]. - The company reduced total common shares outstanding by 4.78% to 294,297,607 as of June 30, 2025, down from 309,067,711 shares in the prior-year period [5]. - Cash and cash equivalents reported at $0.88 million, a decrease from $1.38 million in the prior-year period due to capital deployment for acquisitions [5]. Strategic and Operational Updates - ETST executed its growth strategy by acquiring 100% of Las Villas Health Care, Inc. and DOConsultation, LLC, enhancing its healthcare offerings [5]. - The company secured 80% ownership of Magnefuse, LLC, and Alicat, LLC, expanding its direct-to-consumer brand portfolio [5]. - A new customer service center was established in Doral, FL, to centralize support operations across all divisions [5]. - The company joined the OTCID Tier on the OTC Markets, improving disclosure and transparency for investors [5]. - Mister Meds, LLC is now fully operational and actively dispensing in Texas, while Avenvi, LLC has commenced its first residential development project [5].

Core Insights - Earth Science Tech, Inc. (ETST) has qualified for and been listed on the newly launched OTCID tier of the OTC Markets, reflecting its commitment to enhanced disclosure and compliance standards [1][2] - The CEO, Giorgio R. Saumat, highlighted the company's significant turnaround over the past two years and expressed optimism about future growth and increased investor confidence due to this new designation [3] Company Overview - ETST operates as a strategic holding company focused on acquiring and optimizing high-potential businesses, with current operations in compounding pharmaceuticals, telemedicine, and real estate development through various subsidiaries [4] - The company's subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, and others, each specializing in different aspects of healthcare and real estate [4][10] Subsidiary Highlights - **RxCompoundStore.com**: A fully licensed compounding pharmacy serving multiple states and actively pursuing licensure in remaining U.S. states [5] - **Mister Meds**: A compounding pharmacy in Texas that received full licensure in March 2025 and is expanding its service area [6] - **Peaks Curative**: A telemedicine platform offering consultations for compounded medications and recently expanded into the veterinary market [7] - **Las Villas Health Care**: A healthcare facility focused on the Spanish-speaking community, providing specialized health services [8] - **Avenvi**: A diversified real estate company managing development and financing activities, overseeing a $5 million share repurchase program [10] - **Earth Science Foundation**: A nonprofit organization supporting individuals with financial needs for prescription costs [11]

Company Overview - Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through acquisition, operational optimization, and management of its operating businesses [1] - The company's current operations include compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries [1] Financial Performance - Cash increased to $1,473,228 as of March 31, 2025, up from $697,721 as of March 31, 2024, representing a 111.15% year-over-year improvement [4] - Total assets rose to $7,066,721, compared to $3,881,336 as of March 31, 2024, marking an 82.07% year-over-year increase [4] - Revenue for the fiscal year reached $33,117,624, a significant increase from $11,953,635 for the year ended March 31, 2024, reflecting a 177.05% year-over-year growth [4] - Gross profit was reported at $24,300,136, compared to $7,828,496 for the previous year, indicating a 210.41% year-over-year improvement [4] - Net profit increased to $3,253,635, up from $812,139 for the year ended March 31, 2024, representing a 300.63% year-over-year growth [4] - Outstanding shares decreased to 295,347,903 from 309,981,819 as of March 31, 2024, a reduction of 4.72% [4] Subsidiaries and Operations - RxCompoundStore.com, LLC is a fully licensed compounding pharmacy operating in multiple states and territories, actively pursuing licensure in remaining U.S. states [2] - Mister Meds, acquired on October 1, 2024, received full compounding licensure in March 2025 and operates a facility with advanced sterile compounding capabilities [3] - Peaks Curative, LLC is a telemedicine referral platform offering consultations for compounded medications prepared at RxCompound and Mister Meds [4] - Las Villas Health Care, Inc. provides healthcare services to the Spanish-speaking community, focusing on advanced sexual health treatments [5] - Avenvi, LLC is engaged in real estate development and asset management, overseeing a $5 million share repurchase program [6] - MagneChef is a direct-to-consumer retail brand developing new cooking products utilizing its patents and intellectual properties [7]

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. regarding possible violations of federal securities laws, particularly related to alleged misrepresentations and omissions by the company and its executives [1][2] Group 1: Legal and Regulatory Issues - Novo Nordisk terminated its collaboration with Hims & Hers Health due to serious concerns over the company's sale of compounded medications marketed as personalized treatments, alleging that Hims may have violated regulations by mass-distributing semaglutide-based drugs that could contain unauthorized foreign substances [3] Group 2: Investor Information - Investors who purchased Hims & Hers securities and incurred significant losses may be eligible to participate in a potential class action to recover their losses [2]